Login

Transport Infrastructure Group Before Discussing R&D Site Strategic Factors in Magny-les-Hameaux | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Great Atlantic Salt: Low-Cost, Scalable Mining Opportunity
00:10:00
Exploring Hubbster's SaaS Platform and Newbury's Pharmaceutical Growth | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
Understanding Financial Complexity: Kara Beth Vance Explains Timothy Financial Counsel’s Simple Levels Approach | Kara Beth, Principal , Timothy Financial Counsel.
00:10:00
Banana Capital Invests in companies with category-defining products with differentiated distribution channels|Turner Novak,Founder and Investor,Banana Capital
00:10:00
Early-stage fund led by Shana Fischer|Shana Fischer,General Partner,Third Kind Venture Capital
00:10:00
Manganese X Energy Corp signs MOU with C4V, a leading battery technology firm, potentially securing off-take agreement for high-purity manganese from Battery Hill project for EV batteries.|Martin Kepman, CEO & Director​ of Manganese X Energy Corp
00:10:00
Hydrogen in Focus: Richard Hulf Discusses Industrial Use and Fuel Cell Innovation |Richard Hulf, Co-founder , HydrogenOne Capital Growth Plc.
00:10:00
Expensive Equities: Insights from Columbia Threadneedle Investments
00:10:00
Trevali's Strategic Expansion and Production Highlights
00:10:00
Daetwyler Swisstec - DRUPA 2016 | Volker Cwielong, CEO, Daetwyler Holding AG31D1:FRA
00:10:00
Future of Logistics: E-commerce Surge and Strategic Investments | Marcus Mayer, CEO, Meyer Bergman.
00:10:00
Meridian's Perspective on Renewable Energy, Risk Mitigation, and Market Opportunities | Neal Barclay, CEO, Meridian Energy Ltd.

© 2026 Nehu